Agents and Actions

, Volume 14, Issue 1, pp 102–108 | Cite as

Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP

  • Gillian B. Burns
  • J. A. Dodge
Platelets and Thrombosis


Theophylline (0.05–1.0 mM) greatly enhanced the inhibition of platelet aggregation by prostaglandin E1 and at higher concentrations (1.0–4.0 mM) theophylline alone inhibited platelet aggregation, by a mechanism which did not involve significant changes in platelet cAMP levels. These concentrations of theophylline and theophylline in combination with prostaglandin E1, inhibited the synthesis of thromboxane A2, prostaglandin E2 and F2α in stimulated platelets. Theophylline also inhibited arachidonic acid-stimulated platelet aggregation suggesting an effect on cyclooxygenase activity. The calcium ionophore A23187 prevented and reversed the inhibition of platelet aggregation by theophylline, suggesting that theophylline inhibits the rise in intracellular calcium levels which occurs in response to the synthesis of prostaglandin endoperoxides and thromboxane A2.


Calcium Prostaglandin Theophylline Platelet Aggregation Intracellular Calcium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    M.L. Steer andE.W. Salzman, Cyclic nucleotides in haemostasis and thrombosis. InAdvances in Cyclic Nucleotide Research, vol. 12, pp. 71–92 (Eds.P. Hamet andH. Sands). Raven Press, New York 1980.Google Scholar
  2. [2]
    J.M. Gerrard, J.D. Peller, T.P. Krick andJ.G. White,Cyclic AMP and platelet prostaglandin synthesis, Prostaglandins14, 30–51 (1977).Google Scholar
  3. [3]
    C. Malmsten, E. Granstrom andB. Samuelsson,Cyclic AMP inhibits the synthesis of prostaglandin endoperoxide (PGG 2)in human platelets, Biochem. biophys. Res. Commun.68, 569–576 (1976).PubMedGoogle Scholar
  4. [4]
    J.A. Lindgren, H.E. Claesson, H. Kindahl andS. Hammarstrom, Effects of platelet aggregation and adenosine 3′,5′-monophosphate on the synthesis of thromboxane B2 in human platelets. InAdvances in Prostaglandin and Thromboxane Research, vol. 6, pp. 275–281 (Eds.B. Samuelsson, P.W. Ramwell andR. Paoletti). Raven Press, New York 1980.Google Scholar
  5. [5]
    M. Minkes, N. Stanford, M.M. Chi, G.J. Roth, A. Raz, P. Needleman andP.W. Majerus,Cyclic adenosine 3′,5′-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions, J. clin. Invest.59, 449–454 (1977).PubMedGoogle Scholar
  6. [6]
    D.C.B. Mills andJ.B. Smith,The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′,5′-cyclic monophosphate in platelets, Biochem. J.121, 185–196 (1971).PubMedGoogle Scholar
  7. [7]
    G. Ball, G.G. Brereton, M. Fulwood, A.M. Ireland andP. Yates,The effect of prostaglandin E 1 alone and in combination with theophylline or aspirin on collagen induced platelet aggregation on platelet nucleotides including adenosine 3′,5′-cyclic monophosphate, Biochem. J.120, 709–718 (1970).PubMedGoogle Scholar
  8. [8]
    G.V.R. Born,Aggregation of blood platelets by adenosine diphosphate and its reversal, Nature, Lond.194, 927–929 (1962).Google Scholar
  9. [9]
    W.G. Unger, J.F. Stamford andA. Bennett,Extraction of prostaglandins from human blood, Nature, Lond.233, 336–337 (1971).Google Scholar
  10. [10]
    F. Dray, B. Charbonnel andJ. Maclouf,Radioimmunoassay of prostaglandins F, F 1 and E 2 in human plasma, Eur, J. Clin. Invest.5, 311–318 (1975).Google Scholar
  11. [11]
    M. Hamberg andB. Samuelsson,Prostaglandin endoperoxides. Novel transformation of arachidonic acid in human platelets, Proc. natn. Acad. Sci. USA71, 3400–3404 (1974).Google Scholar
  12. [12]
    O.V. Miller, R.A. Johnson andR.R. Gorman,Inhibition of PGE 1 stimulated cAMP accumulation in human platelets by thromboxane A 2, Prostaglandins13, 599–609 (1977).PubMedGoogle Scholar
  13. [13]
    R.R. Gorman, S. Bunting andO.V. Miller,Modulation of human platelet adenylate cyclase by prostacyclin (PGX), Prostaglandins13, 377–388 (1977).PubMedGoogle Scholar
  14. [14]
    V. Stolc,Control of adenyl cyclase by divalent cations and agonists. Analysis of interactions by the Hill equation, Biochim. biophys. Acta596, 267–276 (1979).Google Scholar

Copyright information

© Birkhäuser Verlag 1984

Authors and Affiliations

  • Gillian B. Burns
    • 1
  • J. A. Dodge
    • 2
  1. 1.Department of Clinical PharmacologySouthampton General HospitalSouthamptonUK
  2. 2.Department of Child HealthWelsh National School of MedicineCardiffSouth Wales, UK

Personalised recommendations